Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
5th
years
Home>>Products>>CAS 75706-12-6 99% Leflunomide Powder

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile:

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

CAS 75706-12-6 99% Leflunomide Powder

CAS NO.75706-12-6

  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T,MoneyGram
Contact Supplier

Product Details

Keywords

  • Leflunomide powder
  • Leflunomide
  • 99% Leflunomide powder

Quick Details

  • ProName: CAS 75706-12-6 99% Leflunomide Powder
  • CasNo: 75706-12-6
  • Molecular Formula: C14H19N5O4
  • Appearance: white
  • Application: anti antiviral
  • DeliveryTime: 7-10 days
  • PackAge: drum
  • Port: Shanghai/Wuhan
  • ProductionCapacity: 1000 Kilogram/Day
  • Purity: 99
  • Storage: room
  • LimitNum: 1 Kilogram

Superiority

 

MOQ: 1kg
Form: Powder
Colour: White
Test: HPLC
Function: anti   antiviral 
Grade: Pharm

 

Details

CAS 75706-12-6 99% Leflunomide Powder 

product Name:    Leflunomide
CAS:75706-12-6
MF:C12H9F3N2O2
MW:270.21
EINECS:    616-254-6
Melting point :166.5 °C
Boiling point :289.3±40.0 °C 
density :1.392±0.06 g/cm3 
storage temp.:2-8°C
solubility :Practically insoluble in water 
form :powder

 What is Leflunomide
Leflunomide is an orally-available disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis (RA) ; it is the first and only drug to be indicated to slow down structural joint damage of RA, so addressing an unmet medical need.

Leflunomide  Function 
 (1) It is hydrogenated acid dehydrogenase inhibitor with immunosuppressive and anti-inflammatory effects for the treatment of adults with active rheumatoid arthritis.
(2) Nonsteroidal anti-inflammatory drug.